SUSAN FALOTICO: Open Payments
NPI 1225522402 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 11 payments from 4 companies in 2025. Trend: 2023 $249 · 2024 $75 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $64 |
| Currax Pharmaceuticals LLC | 3 | $42 |
| Lilly USA, LLC | 2 | $42 |
Products named: Wegovy, VOQUEZNA, CONTRAVE, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
